Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.15
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 333,263
  • Market Cap: £1.76m
  • RiskGrade: 504

Physiomics inks deal to work with Cancer Research UK

By Josh White

Date: Wednesday 12 Oct 2022

LONDON (ShareCast) - (Sharecast News) - Modelling and simulation-focussed consultancy Physiomics that it has signed an agreement to work with Cancer Research UK, it announced on Wednesday.
The AIM-traded firm said it would use its 'PKPD' modelling capabilities to support the Cancer Research UK-sponsored early phase clinical development of 'ALETA-001' - a CAR-T cell engager candidate for the treatment of blood cancers developed by Aleta Biotherapeutics.

It said the PKPD modelling project was expected to be completed during this calendar year.

"We are delighted to be working with Cancer Research UK, the world's leading cancer charity," said chief executive officer Dr Jim Millen.

"Although we have previously worked with clients whose early clinical trials are sponsored by Cancer Research UK's Centre for Drug Development, this project marks the first occasion on which Physiomics has worked directly with Cancer Research UK."

At 1148 BST, shares in Physiomics were up 26.19% at 2.65p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Physiomics Market Data

Currency UK Pounds
Share Price 1.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.15
52 Week Low 0.95
Volume 333,263
Shares Issued 135.47m
Market Cap £1.76m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.08% below the market average31.08% below the market average31.08% below the market average31.08% below the market average31.08% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Trend
80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average
Income Not Available
Growth
59.46% below the market average59.46% below the market average59.46% below the market average59.46% below the market average59.46% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

Physiomics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:18 41,584 @ 1.20p
16:16 62,500 @ 1.20p
15:05 15,094 @ 1.33p
14:44 2,285 @ 1.20p
13:21 53,219 @ 1.23p

Physiomics Key Personnel

COO Christophe Chassagnole
CEO Peter Sargent

Top of Page